Anagenix, founded in New Zealand, is a nutraceutical company that transforms locally sourced, non-GMO whole fruits—such as kiwifruit, boysenberries, apples, and feijoas—into clinically validated functional ingredients: Actazin®, Livaux®, BerriQi®, and Feiolix®. Using proprietary freeze-drying methods, the bioactive potency of these products is maximised while promoting sustainability by utilising imperfect fruit and ensuring full traceability from orchard to factory.
Anagenix is deeply rooted in science, partnering with research institutions and universities, and holds multiple patents, peer-reviewed publications, clinical trials, and regulatory approvals, including an FSANZ health claim for Actazin®. Guided by values of responsibility, expertise, trusted service, New Zealand origin, credible science, and customer engagement, Anagenix distributes its products globally through more than 20 local partners across Asia, Europe, North America, and other regions.